L & S Advisors’s Annovis Bio ANVS Stock Holding History

L & S Advisors’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-19,530	Closed	-$1.67M	–	336
2021 Q2	$1.67M	Buy	+19,530	New	+$902K	0.18%	170

Other funds holding ANVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

WFAG

Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

L & S Advisors's ANVS Position: Q3 2021 in Review

L & S Advisors sold out of Annovis Bio (ANVS) in Q3 2021, closing a stake of 19,530 shares — an estimated $1.67M sold.

L & S Advisors first reported a position in ANVS in Q2 2021 and held it in 1 quarter. The position peaked at $1.67M in Q2 2021. 38 funds tracked by Wall St. Rank hold ANVS as of Q3 2021.

L & S Advisors reported no remaining Annovis Bio position as of Q3 2021 after selling out during the quarter.
L & S Advisors sold 19,530 Annovis Bio shares in Q3 2021, an estimated $1.67M.
L & S Advisors first reported a position in Annovis Bio in Q2 2021 and held it in 1 quarter.
L & S Advisors's Annovis Bio position peaked at $1.67M in Q2 2021.
38 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2021.

Based on L & S Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.